XNCR Chart
See on advanced chart >
About
Xencor, Inc. was incorporated in California in August 1997 and reincorporated in Delaware in September 2004. The company is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine...
Read More
- HighlightA biotech company that develops monoclonal antibodies for cancer and autoimmune diseases
- ExchangeNASDAQ
- Listing Date12/03/2013
- Established DateInvalid Date
- Full-time Employees280
- Address465 North Halstead Street Suite 200 Pasadena CA 91107
- Tel1-626-3055900
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology